INHALATION TOXICITY OF 4-ETHOXYANILINE (p-PHENETIDINE): CRITICAL ANALYSIS OF RESULTS OF SUBACUTE INHALATION EXPOSURE STUDIES IN RATS

Authors: Pauluhn, Jürgen; Mohr, Ulrich

Source: Inhalation Toxicology, Volume 13, Number 11, 1 November 2001 , pp. 993-1013(21)

Publisher: Informa Healthcare

Buy & download fulltext article:

OR

Price: $35.96 plus tax (Refund Policy)

Abstract:

This article addresses results from a single 4-h and repeated 1- and 4-wk inhalation exposure studies in Wistar rats with vapor and/or aerosol atmospheres of 4-ethoxyaniline (p-phenetidine). Groups of 10 rats/sex were exposed nose-only to mean analytical concentrations of 11.1, 86.2, and 882.6 mg p-phenetidine/m3 using an exposure regimen of 6 h/day, 5 days/wk for 4 wk. Concentrations were selected based on results from a pilot study in which rats were exposed under identical conditions on 5 consecutive days for 6 h/day to mean analytical concentrations of 38.2, 133.0, and 1247.6 mg/m3. In repeated exposure studies, the focus of endpoints was on hematotoxicity. The LC50 was not determined, but no rats died following a single 4-h exposure to 5085 mg/m3 as a mixture of vapor and aerosol. No mortality was observed either in the 1- or 4-wk studies. Rats exposed to 882.6 mg/m3 and above evoked characteristic signs of toxicity that included cyanosis, with no apparent progression of findings during the exposure period. Animals exposed to 86.2 mg/m3 and above exhibited a concentration-dependent, significant increase in blood methemoglobin and reticulocyte counts as well as a significant decrease in hemoglobin, hematocrit, and red blood cell counts. Spleen weights were significantly increased in groups exposed to 133.0 mg/m3 and above. Microscopic changes demonstrated an increased hematopoiesis (bone marrow smears) and splenic hemosiderosis at 86.2 and 882.6 mg/m3 and a hepatic hemosiderosis only at 882.6 mg/m3. These data suggest that the toxicity of p-phenetidine is similar to that of its structural analog aniline. Based on the erythrocytotoxicity occurring at 86.2 mg/m3 and above, including the apparent reactive changes in bone marrow (increased erythropoiesis) and spleen (increased erythroclasia), the no-observed-adverse-effect level (NOAEL) of the 4-wk study was 11.1 mg/m3 air and that of the 1-wk study was 38.2 mg/m3 air. This difference in NOAELs is considered to be related to the selection of exposure concentrations rather than cumulative toxicity.

Document Type: Research Article

DOI: http://dx.doi.org/10.1080/089583701753210371

Publication date: November 1, 2001

More about this publication?
Related content

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page